Zobrazeno 1 - 10
of 1 747
pro vyhledávání: '"Modified release"'
Autor:
Pravinkumar Dinkar Lade, Neelam Singla
Publikováno v:
BIO Integration, Vol 5, Iss 1 (2024)
Background: Natural polysaccharide tara gum (TG) has been investigated for several biological uses. The current study involved the administration of imatinib, an anticancer model medication, via TG. Methods: Imatinib-modified release tablets were dev
Externí odkaz:
https://doaj.org/article/16832da7c77e4e4dba98084fe14d0c9e
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Chrystalla Protopapa, Angeliki Siamidi, Aikaterini Sakellaropoulou, Siva Kolipaka, Laura Andrade Junqueira, Atabak Ghanizadeh Tabriz, Dennis Douroumis, Marilena Vlachou
Publikováno v:
Pharmaceuticals, Vol 17, Iss 8, p 1017 (2024)
An innovative approach for creating customized dosage forms and supporting patient populations with specific requirements who need additional support to improve drug adherence is 3D printing. This work introduces liquid crystal display (LCD) 3D print
Externí odkaz:
https://doaj.org/article/17d5664365d745858e93d29da285793e
Publikováno v:
罕见病研究, Vol 2, Iss 3, Pp 436-441 (2023)
Adrenal insufficiency is a disease characterized by insufficient secretion of adrenocortical hormones, usually treated with glucocorticoid replacement therapy. The routine drugs have two forms-short-acting and long-acting. The shorter one should be t
Externí odkaz:
https://doaj.org/article/17bdb778a8e6479285a9b04ea8ae97a0
Publikováno v:
Heliyon, Vol 10, Iss 3, Pp e25820- (2024)
Hypertension is one of the major causes of mortality in the world. The non-selective -β-blocker which includes Timolol maleate (TM) is usually used in hypertension, at a given dose of 10–40 mg. The present research aims to design a tablet-in-table
Externí odkaz:
https://doaj.org/article/8a0c0cdc83a44ff4bb04602ed2aad518
Autor:
Mohammed Farid Uddin, Murshed Ahamed Khan, Shahjada Selim, Nusrat Sultana, Mohammad Abu Sayem, Mohammed Mahboob Iftekhar, Maruf Bin Habib, Nazma Akter, Shahjamal Khan
Publikováno v:
Journal of Comparative Effectiveness Research, Vol 13, Iss 2 (2024)
Aim: Many Muslims with Type II diabetes (T2DM) fast during Ramadan, which can put them at increased risk of hypoglycemia. This sub-analysis of the global DIA-RAMADAN study assessed the effectiveness and safety of gliclazide modified release (MR) 60
Externí odkaz:
https://doaj.org/article/0881fecd1baa4089931521b31c291709
Autor:
Hoshun Chong, Yaxuan Gao, Yunxing Xue, Xiyu Zhu, Jie Li, Junxia Wang, He Zhang, Dongjin Wang, Hailong Cao
Publikováno v:
Journal of Cardiothoracic Surgery, Vol 18, Iss 1, Pp 1-5 (2023)
Abstract Objective Repair or replacement remains debatable in rheumatic heart disease. To regain optimal mean transvalvular pressure gradients and end-diastolic peak flow velocity, the modified release technique combined peeling in the anterior leafl
Externí odkaz:
https://doaj.org/article/066d0533db4f49eda4c7e2cd021b8859
Publikováno v:
Pharmaceutics, Vol 16, Iss 4, p 498 (2024)
The mathematical models available in DDSolver were applied to experimental dissolution data obtained by analysing carvedilol release from hypromellose (HPMC)-based matrix tablets. Different carvedilol release profiles were generated by varying a comp
Externí odkaz:
https://doaj.org/article/42896bd2994c47839cb3caaf6804fc71
Publikováno v:
Drug Design, Development and Therapy, Vol Volume 16, Pp 4439-4448 (2022)
In Sun Goak,1,2 Jin A Lee,1,3 Min Ho Jeong,4 Seol Ju Moon,1,3 Min Gul Kim1,3,5 1Department of Pharmacology, School of Medicine, Jeonbuk National University, Jeonju, Republic of Korea; 2Division of Endocrinology and Metabolism, Department of Internal
Externí odkaz:
https://doaj.org/article/022f46770152417a920ce51bdd284689
Publikováno v:
Разработка и регистрация лекарственных средств, Vol 11, Iss 4, Pp 134-140 (2022)
Introduction. The article presents the results of the development of the composition and technology of orally dispersed tablets of ethylthiobenzimidazole fumarate – a new actoprotective and adaptogenic agent.Aim. Development and substantiation of t
Externí odkaz:
https://doaj.org/article/7d5f8967e39f43d6a22e7a9e68107736